LataMed AI LMED
OTC LMED
$0.07 -0.02 (-22.22%)
At close: Sep 28, 2026 · 4:00 PM EDT

LataMed AI (LMED) Common Equity (2023 - 2026)

Updated

LataMed AI's Common Equity came in at $7.14 million for Q1 2026, compared with -$598,030 a year earlier.

Analysis

LataMed AI (LMED) Common Equity (2023 - 2026) Analysis & Trends

At the end of FY2025, LataMed AI's Common Equity was -$630,860.

  • Going back by year, Common Equity was -$573,575 in FY2024 and -$500,363 in FY2023.
  • The Q1 2026 figure represents the highest quarterly Common Equity in data going back to Q2 2023.
  • Business Quant data shows LMED's Common Equity at -$630,860 (Q4 2025), -$663,514 (Q3 2025) and -$627,212 (Q2 2025) in the three quarters before Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Palo Alto Networks 319.55 Bn 304.63 Bn 2.30 Bn 27.49 Bn
2 CrowdStrike Holdings 265.46 Bn 245.90 Bn 1.10 Bn 5.14 Bn
3 Fortinet 129.36 Bn 115.29 Bn 1.64 Bn 1.55 Bn
4 Snowflake 115.65 Bn 102.97 Bn 1.04 Bn 2.15 Bn
5 Datadog 96.45 Bn 78.09 Bn 881.34 Mn 4.37 Bn
6 Axon Enterprise 34.50 Bn 29.03 Bn 546.45 Mn 3.67 Bn
7 Okta 33.79 Bn 23.89 Bn 641.00 Mn 6.97 Bn
8 Zscaler 32.51 Bn 18.63 Bn - 2.60 Bn
9 Baidu 29.59 Bn -44.04 Bn 1.47 Mn 41.48 Bn
10 LataMed AI 3.93 Mn 3.93 Mn - 7.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 7.14 Mn
Dec 31, 2025 -630,860.00
Sep 30, 2025 -663,514.00
Jun 30, 2025 -627,212.00
Mar 31, 2025 -598,030.00
Dec 31, 2024 -573,575.00
Sep 30, 2024 -647,971.00
Jun 30, 2024 -604,490.00
Mar 31, 2024 -542,583.00
Dec 31, 2023 -500,363.00
Sep 30, 2023 454,410.00
Jun 30, 2023 464,746.00
API Access

LataMed AI Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=LMED&period=max&api_key=YOUR_API_KEY